← Open Payments lookup

MARIE CHARLES: Open Payments

NPI 1447407507 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,882 in 50 payments from 11 companies in 2025. Trend: 2023 $1,162 · 2024 $4,358 · 2025 $2,882

Food & beverage: $2,882
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.13$690
E.R. Squibb & Sons, L.L.C.6$565
Janssen Pharmaceuticals, Inc5$350
Alkermes, Inc.5$331
Luye Pharma (USA) Ltd.8$281
Teva Pharmaceuticals USA, Inc.4$177
Phathom Pharmaceuticals, Inc.1$125
Takeda Pharmaceuticals U.S.A., Inc.1$119
Gilead Sciences, Inc.1$119
Otsuka America Pharmaceutical, Inc.3$66

Products named: INGREZZA, COBENFY, ERZOFRI EXTENDED-RELEASE, ARISTADA, INVEGA SUSTENNA, UZEDY, SPRAVATO, VOQUEZNA.

Industry payments across NY — which companies pay providers there.